Medical Journals

Fgf-2 Deficiency Does Not Alter Vulnerability of the Dopaminergic Nigrostriatal System Towards Mptp Intoxication in Mice.

Authors:
  • Zechel S
  • Jarosik J
  • Kiprianova I
  • Schober A
  • Unsicker K
  • von Bohlen und Halbach O

From: Interdisciplinary Center for Neurosciences (IZN), Department of Neuroanatomy, University of Heidelberg, Im Neuenheimer Feld 307, D-69120 Heidelberg, Germany.

The European journal of neuroscience

  • Publish Date: Mar 2006
  • ISSN: 0953-816X
  • Volume: 23
  • Issue: 6
  • Pages: 1671-5
  • Medium: Print
  • Language: English
  • Citation (JAMA): Zechel S, Jarosik J, Kiprianova I, et al. Fgf-2 Deficiency Does Not Alter Vulnerability of the Dopaminergic Nigrostriatal System Towards Mptp Intoxication in Mice.. Eur. J. Neurosci. Mar 2006;23:1671-5

Abstract

Fibroblast growth factor 2 (FGF-2) was the first growth factor discovered that exerted prominent protective and regenerative effects in an animal model of Parkinson’s disease, the MPTP-lesioned dopaminergic nigrostriatal system. To address the putative physiological relevance of endogenous FGF-2 for midbrain dopaminergic neurons, we have analysed densities of tyrosine hydroxylase (TH)-positive cells in the substantia nigra (SN) and TH-positive fibers in the striatum and amygdala of adult FGF-2-deficient mice. We found that densities of TH-immunoreactive (ir) cells in the SN as well as densities of TH-ir fibers in the striatum and amygdala were unaltered as compared with wild-type littermates. There is evidence to suggest that growth factor deficits do not become apparent unless a system is challenged in a lesioning paradigm. We therefore tested the ability of the nigrostriatal system with respect to its ability to cope with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) intoxication. Treatment with 20 mg/kg MPTP on three consecutive days reduced dopamine levels in the striatum by about 80%. Densities of TH-positive neurons in the SN were reduced by 71%. However, both parameters did not significantly differ between FGF-2(-/-) mice and wild-type littermates. Our results therefore suggest that FGF-2, despite its prominent pharmacological potency as a neurotrophic factor for the dopaminergic nigrostriatal system, is not crucial for maintaining its structural integrity and ability to cope with MPTP intoxication.

Mesh Headings (Keywords): 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Amygdala, Animals, Axons, Dopamine, Dopamine Agents, Fibroblast Growth Factor 2, Immunohistochemistry, Mice, Mice, Knockout, Neostriatum, Substantia Nigra, Tyrosine 3-Monooxygenase


Check for Full Text / PubMed Unique Identifier (PMID): 16553632


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.